FIG. 4.
Reactivity of anti-P. berghei liver-stage serum antibodies to PfLSA-1-based peptides in an ELISA. Anti-P. berghei liver-stage sera were generated by injecting 1 million infected hepatocytes intravenously into a group of 10 naive BALB/c mice. Two weeks later, sera were collected from all immunized mice and pooled together. Negative-control values were obtained by incubating peptides with normal mouse serum antibodies and did not exceed an OD of 0.02.
